The Peptide Blueprint™

The Peptide Blueprint series includes 40+ free evidence-graded research guides covering peptide protocols, GLP-1 agonists (semaglutide, tirzepatide, retatrutide), reconstitution techniques, stacking strategies, bloodwork interpretation, regulatory status and legal analysis, anti-aging compounds, and advanced compound science. Papers range from beginner introductions to detailed clinical evidence reviews. All are downloadable and shareable under a Creative Commons license.

Each white paper is reviewed by the Path to Peptides research team using a structured editorial process. This includes verification of all cited studies against PubMed, evidence grading using a modified GRADE framework, factual accuracy checks, and consistency with current clinical data. Papers are updated when significant new research emerges, and each includes a last-reviewed date for transparency.

Yes. The Path to Peptides team welcomes research contributions and topic suggestions. If you have peer-reviewed research, clinical data, or a topic proposal relevant to peptide science, you can submit it for editorial review. Accepted contributions are credited and published as part of the Peptide Blueprint series. Contact the team through the site's contact page.